According to the indictment, from around September 2018 to 2022, Dr. Emery unlawfully prescribed and distributed buprenorphine, a Schedule III controlled substance, according to a Sept. 29 news release from the U.S. Justice Department.
He is charged with one count of conspiracy to distribute controlled substances and 11 counts of distribution of controlled substances outside the bounds of professional medical practice. He faces a maximum penalty of 10 years in prison and a $500,000 fine on each count if convicted.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.